SEC Form 4 · accession 0001179110-15-014072
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norbert W Bischofberger
Officer — EVP, R&D and CSO
Period of report
Oct 15, 2015
Accepted (ET)
Oct 16, 2015 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 15, 2015 | M | 68,400 | $23.60 | A | 233,568 | D | |
| Common Stock | Oct 15, 2015 | M | 1,600 | $23.755 | A | 235,168 | D | |
| Common StockF3 | Oct 15, 2015 | S | 3,200 | $98.0171 | D | 231,968 | D | |
| Common StockF4 | Oct 15, 2015 | S | 26,105 | $99.246 | D | 205,863 | D | |
| Common StockF5 | Oct 15, 2015 | S | 15,376 | $99.961 | D | 190,487 | D | |
| Common StockF6 | Oct 15, 2015 | S | 25,319 | $101.1789 | D | 165,168 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $23.60 | Oct 15, 2015 | M | 68,400 | D | — | Jan 21, 2019 | Common Stock | 68,400 | 0 | D |
| Non-Qualified Stock Option (right to buy)F2 | $23.755 | Oct 15, 2015 | M | 1,600 | D | — | Jan 28, 2020 | Common Stock | 1,600 | 142,400 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $97.62 to $98.54. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $98.63 to $99.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request
- F5Sale prices reported for the transactions reported here range from $99.63 to $100.59. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $100.64 to $101.625. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.